A : Scanning electron microscopi c image shows a Silastic tympanostomy tube that was removed pam a pa tient with chronic otorrhea. B: At higher magnification, microbes in an extracellular matrix (i.e.. biofilm) are seen sca ttered over the surface ofthe tube. .
The emergence oft he biofilm model of otitis medi a holds tremend ous potenti al implications for treatment. Biofilm s are thought by many investigator s to be the underlying cause of most recalcitr ant infecti ons.I Biofilm s impart resistance both to host immune defense mechanisms-' and antibiotic treatment.' Simpl y changing antibiotics or raising their level s will prove futile in the case of most patho gen s and antimicrobial agent s because a biofilm elevates minimum inhibitory concent ration s well beyond what ca n be delivered with systemic therapy .' Ototopical therapy can deliv er much higher antibiotic con centr ations, which may or may not be sufficient to achieve microbi al inhibition or killing.v"
Biofilm-mediated survival of pathogens in the presence of antibiotics promotes the developm ent of res istant planktoni c forms." Thi s effectively extends the imp act of biofilm-mediated resistance to infections that are not medi ated by biofilm s. If systemic antimicrobial therapy is unlik ely to eradicate a biofilm-mediated infection and such therapy may well propagate resistance, restricti on of systemic antibiotic therapy in biofilm-mediated infections must be considered.
Mechanisms of biofilm-mediated resistance
The mechanisms responsible for biofilm-m ediat ed antibiotic resistance are poorly und erstood. The exopolymeri c matri x may impede the diffu sion of some antibiotic s, but it will not prevent microbial cell death." Lysis of the matrix does not necessarily return antimicrobial sensitivities to plan ktoni c patterns immediately.'?
The presenc e of beta-Iactamase-producin g stra ins of Pseudom ona s aeruginosa increases in the biofilm state.II Drug efflux pumps, which play key roles in the resistance of planktonic micro organ isms, may also play a role in biofilm-phenotype resistance to some antimicrobial age nts (e.g., ofloxaci n but not ciprofloxacin)." Subp opulations of super-res istant bacteria have been reported in biofilms of pathogens that are deficient in energy-dependent resis tance mecha-nisrns.'?The se organisms are thou ght to be metabolically dormant. Unfortunately, treatment strategies based on these microbi al mechanisms of biofilm resistance are lacking.
Disruption of biofilms
Disrupt ion of microbial biofilms is routinely acco mplished in laboratory models by the application of ultrasound and/or detergent s. Unfortun ately, neithe r treatment is practical in vivo becau se both are potent ially dam aging to the inne r ear. 12 • 13 Furth ermore, efforts to disrupt biofilm s must avoid cau sing damage to the beneficial biofilm s that are found throughout the body because a loss of commensal organisms in biofilm may also lead to disease states (e.g., thru sh).
Modul ating the host response to biofilm-forming pathogens may prove to be an effectiv e alterna tive for treatin g biofilm-m ediated infections. Bacterial toxins secreted from the biofilm lead to a host inflammatory response. Post sugges ted that "co llateral damage" from the host inflammato ry response may be responsible for the persistence of middl e ear inflamm ation in chronic otitis media with effusion." Parad oxically, P aeruginosa biofilm formation is promoted by the presence of lysed neutrophils ." Neutrophil s are vulnerable to the cell lysis that occurs as a result of the produ ction of Pseud omonas toxin s in biofilm phenotyp es. This vicio us cycle prom otes biofilm developm ent. 16 Attenu ating the host inflammatory respon se with corticostero ids, either alon e or in combination with antibiotics, has proven to be bene ficial in the treatment of otitis med ia and otitis externa. 
Prevention of biofilms
With the options avail able for treatin g es tablished biofilm diseases so lim ited , we must con sider intervent ion aimed at preventin g biofilm formation. However, there is very littl e literature that address es such possibilities. In vitro data sugges t that earl y antimicrobial intervention, even with immature biofilm formation, may be more advantageous relative to the eradication of mature biofilms." Early antimicrobial intervent ion does, how ever, conflict with the Centers for Disea se Control and Prevention 's recommend ation to withhold antibiot ics for early disease, such as uncomplicated otitis media.
With the options available for treating established biofilm diseases so limited , we must consider intervention aimed at preventing biofilm formation .
The potenti al for pre venting or treating biofi lm dev elopment is greatest in pati ent s with post-tympanostomy tube otorrhea. Bacteri al adh erence and biofilm formation may be prevented by avoiding tympanostomy tube exposure to blood (i.e., by meticulou s surgical technique)." Biofilm formation (figure) might also be avoid ed by coating the tube 's surface with albuminv -" or by using tube s composed of biofilm-resistant materials." Most research to date has suggested that using the smoothest bio material with the fewe st recesses will yield the lowe st risk of biofilm formari on.P-" Finally, certain engineered surface microtop ographi es (e.g ., those that resemb le shark skin) have been shown to dram atically decrease the development of biofilms.? By reducing biofilm formation on tympanostomy tub es, reduction in post-tympanostomy tube otorrhea and tube occlu sion may be possible.v"
